Feed LNMG
LN

Linike Medical Group Ltd

LNMG · OTC

$0.01 +3.64% (+$0.00)
1M +7.55%
Market Cap $3.81M
P/E Ratio 1.24x
Div. Yield -
ROE 8.05%
Piotroski F-Score Moderate
5/9
Valuation
100 /100
Cheap
P/S 0.36x
P/E 1.24x
P/B 0.10x
Growth
-
N/A
FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
70 /100
Strong
Op. margin 28.91%
Gross margin 98.76%
FCF margin 2.46%
Quality
32 /100
Poor
ROA 5.35%
ROIC 5.57%
Asset turnover 0.19x
Debt
53 /100
Moderate
Net debt/EBITDA 5.25x
Debt/Equity 0.46x
Current ratio 3.99x
Stability
23 /100
Unstable
Profitable years 1
Beta -3.09x
EPS volatility 912.79%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about LNMG
Online

Sector

Consumer Cyclical

Industry

Specialty Retail

CEO

Jian Wang

Employees

0

Headquarters

Calgary

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.